The Precision Onco Haemyeloid NGS Panel uses next-generation sequencing to identify the specific genetic mutations driving a patient's blood cancer, information that increasingly shapes treatment choice. Blood cancers such as leukaemia and myelodysplastic syndromes often behave differently depending on their underlying mutations, even when they look similar under a microscope. At UMC Victoria Hospital, our Department of Cancer offers this precision onco haemyeloid NGS panel testing in Uganda as part of a precision-guided approach to haematological cancers:
This panel is typically recommended for patients newly diagnosed with a blood cancer or those whose disease isn't responding as expected. Consult our team for further medical assistance.
Group Member of 
